These studies will evaluate the role of the mitochondrial manganese superoxide dismutase (Sod2) in the regulation of matrix metalloproteinase (MMP) expression and metastatic invasion. We have established that the Sod2-dependent H202 production is sufficient and required for MMP-1 expression. The ability of Sod2 overexpression to modulate MMP expression appears to be dependent on signaling through Ras and the ERK1/2 cascade. This signaling cascade may be utilized under a variety of conditions where Sod2 levels are elevated. We have also established that invasion, metastasis and MMP expression are enhanced in an H202-dependent fashion when Sod2 is overexpressed. These observations may explain a number of reports suggesting that Sod2 overexpression is linked to an increase in metastatic cancers. More importantly we have shown that Sod2 and MMP-1 functionally interact. This latter observation is quite provocative, as SNPs in either of these proteins have independently been linked to increased incidence of various forms of cancer. It has been proposed that the Sod2 polymorphism increases its activity. Our findings indicate that increases in Sod2 activity can increase the transcriptional activity of both the native and polymorphic MMP-1 promoter. Furthermore, only subtle changes in Sod2 levels are required to modulate MMP-1 expression. The proposed studies will: (1) establish the link between Sod2, MMPs and metastasis, (2) define the molecular mechanisms that modulate MMP expression in response to Sod2-dependent production of H2O2, (3) determine if a synergy between the Sod2 and MMP-1 levels or polymorphisms exist, and (4) develop redox-based adenoviral vectors that target metastatic tumor cells for destruction.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Career Transition Award (K22)
Project #
1K22CA095011-01
Application #
6460443
Study Section
Subcommittee G - Education (NCI)
Program Officer
Wali, Anil
Project Start
2002-07-01
Project End
2005-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
1
Fiscal Year
2002
Total Cost
$148,527
Indirect Cost
Name
Albany Medical College
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Albany
State
NY
Country
United States
Zip Code
12208
Kanga-Parabia, Anaita; Gaff, Clara; Flander, Louisa et al. (2018) Discussions about predictive genetic testing for Lynch syndrome: the role of health professionals and families in decisions to decline. Fam Cancer 17:547-555
Savio, Andrea J; Daftary, Darshana; Dicks, Elizabeth et al. (2016) Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients. BMC Cancer 16:113
Garcia-Albeniz, Xabier; Rudolph, Anja; Hutter, Carolyn et al. (2016) CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk. Br J Cancer 114:221-9
Thrift, Aaron P; Gong, Jian; Peters, Ulrike et al. (2015) Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol 44:662-72
Lemire, Mathieu; Zaidi, Syed H E; Ban, Maria et al. (2015) Long-range epigenetic regulation is conferred by genetic variation located at thousands of independent loci. Nat Commun 6:6326
Lemire, Mathieu; Zaidi, Syed H E; Zanke, Brent W et al. (2015) The effect of 5-fluorouracil/leucovorin chemotherapy on CpG methylation, or the confounding role of leukocyte heterogeneity: An illustration. Genomics 106:340-7
Win, Aung Ko; Buchanan, Daniel D; Rosty, Christophe et al. (2015) Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut 64:101-10
Yurgelun, Matthew B; Masciari, Serena; Joshi, Victoria A et al. (2015) Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol 1:214-21
Nan, Hongmei; Hutter, Carolyn M; Lin, Yi et al. (2015) Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants. JAMA 313:1133-42
Flander, Louisa; Speirs-Bridge, Andrew; Rutstein, Alison et al. (2014) Perceived versus predicted risks of colorectal cancer and self-reported colonoscopies by members of mismatch repair gene mutation-carrying families who have declined genetic testing. J Genet Couns 23:79-88

Showing the most recent 10 out of 165 publications